Skip to main content

Research Repository

Advanced Search

How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals

Moledina, Zahra; McPhee, Margaret; Ravenscroft, Jane C.; Healy, Eugene; Radley, Kathy; Thomas, Kim S.; Burden-Teh, Esther; Acne -ID Trial Development Team

Authors

Zahra Moledina

Margaret McPhee

Jane C. Ravenscroft

Eugene Healy

Kathy Radley

Acne -ID Trial Development Team



Abstract

We undertook a survey of UK healthcare professionals through the UKDCTN and BDNG to understand clinicians’ routine practice prescribing oral isotretinoin for treatment of acne vulgaris (acne). We also wanted to understand clinicians’ experiences and views on prescribing low daily dose regimens. Overall, the survey showed that clinicians adopted a patient-centred approach when deciding isotretinoin dosing. The rationale for using a low-dose regimen varied, but was focused on patient wellbeing during treatment. Some clinicians were concerned that use of a low-dose regimen could be less effective and lead to longer treatment durations. The survey results will be useful to inform a clinical trial investigating the effectiveness and safety of low daily dose isotretinoin for the treatment of acne.

Citation

Moledina, Z., McPhee, M., Ravenscroft, J. C., Healy, E., Radley, K., Thomas, K. S., …Acne -ID Trial Development Team. (2023). How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals. Clinical and Experimental Dermatology, 48(1), 20-23. https://doi.org/10.1093/ced/llac015

Journal Article Type Article
Acceptance Date Sep 15, 2022
Online Publication Date Oct 20, 2022
Publication Date Jan 20, 2023
Deposit Date Oct 7, 2022
Publicly Available Date Oct 21, 2023
Journal Clinical and Experimental Dermatology
Print ISSN 0307-6938
Electronic ISSN 1365-2230
Peer Reviewed Peer Reviewed
Volume 48
Issue 1
Pages 20-23
DOI https://doi.org/10.1093/ced/llac015
Keywords Dermatology
Public URL https://nottingham-repository.worktribe.com/output/12034651
Publisher URL https://academic.oup.com/ced/article/48/1/20/6764863
Additional Information This is the peer reviewed version of the following article: Zahra Moledina, Margaret McPhee, Jane C Ravenscroft, Eugene Healy, Kathy Radley, Kim S Thomas, Esther Burden-Teh, Acne-ID Trial Development Team, How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals, Clinical and Experimental Dermatology, Volume 48, Issue 1, January 2023, Pages 20–23, which has been published in final form at https://doi.org/10.1093/ced/llac015]. The article must be linked to Wiley’s version of record on Wiley Online Library.

Files

How is oral isotretinoin prescribed for the treatment of acne vulgaris (464 Kb)
PDF




You might also like



Downloadable Citations